Frequency of the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene in patients with migraine with or without aura - A preliminary report;Częstość występowania wariantu C677Tgenu MTHFR u pacjentów z migreną z aurą i bez aury - Doniesienie wstępne

Neurologia i Neurochirurgia Polska

Volumn 46, Issue 5, 2012, Pages 443-449

  Szczygioł, Dorota ^a   Motta, Ewa ^a   Gołba, Anna ^a   Steposz, Arkadiusz ^a   Witecka, Joanna ^a   Debski, Marek ^a   Błaszkiewicz, Daria ^a   Sieroń, Aleksander ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Migraine; MTHFR gene; Patent foramen ovale

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MTHFR GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; RISK FACTOR; VALSALVA MANEUVER;

EID: 84869217628     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.5114/ninp.2012.31354     Document Type: Article

References (31)

1. Nowakowski T., Jagustyn P., Maksymiuk G. Migrena-impli-kacje patofizjologiczno-terapeutyczne. Pol Przegl Med Lotn 2007; 1: 85-94.
2. Lea R.L., Ovaric M., Sundholm J., et al. The methyleno tetra-hydrofolate reductase gene variant C677T influences susce pti-bility to migraine with aura. BMC Medicine 2004; 2: 3.
3. Oterino A., Valle N., Bravo Y., et al. MTHFR T677 homo-zygosis influences the presence of aura in migreneurs. Cephalgia 2004; 24: 491-494.
4. Schürks M., Rist P.M., Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache 2010; 50: 588-599.
5. 3adu nerwowego. Forum Med Rodz 2008; 2: 223-228.
6. Piechowski-JóŸwiak B., Kwieciñski H. Rola dro¿nego otworu owalnego w patogenezie udaru niedokrwiennego. Kardiologia po Dyplomie 2005; 3: 26-28.
7. Headache Classification Committee of the International Head-ache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain, 2nd edition. Cephalalgia 2004; 24: 1-160.
8. Kowa H., Yasui K., Takeshima T., et al. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000; 96: 762-764.
9. Marcus H.S., Harrison M. Estimation of cerebrovascular reactivity using transcranial doppler, including the use of breathholding as the vasodilatory stimulus. Stroke 1992; 23: 669-673.
10. Jauss M., Zanette E. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 2000; 10: 490-496.
11. Kozera G., Nyka W. Próba TCD na PFO-znaczenie kliniczne i ograniczenia. Pol Przegl Neurol 2004; 4 (supl. A): 58-59.
12. 1. Neurol Neurochir Pol 2004; 38: 89-92.
13. Tietjen E.G. Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalgia 2007; 27: 981-987.
14. de Tommaso M., Difruscolo O., Sardaro M., et al. Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine. Headache 2007; 47: 253-265.
15. Pezzini A., Grassi M., Del Zotto E., et al. Migraine mediates the influence of C667T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 2007; 38: 3145-3151.
16. Schürks M., Zee R.Y., Buring J.E., et al. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 2008; 71: 505-513.
17. Ferro A., Castro M.J., Lemos C., et al. The C677T poly mor-phism in MTHFR is not associated with migraine in Portugal. Dis Markers 2008; 25: 107-113.
18. Bottini F., Celle M.E., Calevo M.G., et al. Metabolic and genetic risk factors for migraine in children. Cephalgia 2006; 26: 731-737.
19. Kara I., Sazci A., Ergul E., et al. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003; 111: 84-90.
20. Kaunisto M.A., Kallela M., Hamalainen E., et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 2006; 26: 1462-1472.
21. Oterino A., Valle N., Pasqual J., et al. Thymidylate synthase promoter tandem repeat and MTHFD1 R 653Q polymor-phisms modulate the risk for migraine conferred by the MTHFR T677 allele. Brain Res Mol Brain Res 2005; 139: 163-168.
22. Scher A., Terwindt G.M., Verschuren W.M., et al. Me and MTHFR C677T genotype in population-based sample. Ann Neurol 2006; 59: 372-375.
23. Todt U., Freundenberg J., Goebel I., et al. MTHFR C677T polymorphism and migraine with aura. Ann Neurol 2006; 60: 621-622.
24. Liu A., Menon S., Colson N.J., et al. Analysis of the MTHFR C677T variant with migraine phenotypes. BMC Res Notes 2010; 28: 213.
25. Schürks M., Rist P.M., Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine. A systematic review and metaanalysis. Headache 2010; 50: 588-599.
26. Lea R., Colson N., Quinlan S., et al. The effects of vitamin supplementation and MTHFR(C677T) genotype on homo-cysteine-lowering and migraine disability. Pharmacogenet Genomics 2009; 19: 422-428.
27. Hering Hanit R., Gadoth N., Yavetz A., et al. Is blood homo-cysteine elevated in migraine? Headache 2001; 41: 779-781.
28. Oterino A., Toriello M., Valle N., et al. The relationship between homocysteine and genes of folate-related enzymes in migraine patients. Headache 2010; 50: 99-168.
29. Rigatelli G. Migraine and patent foramen ovale: connecting flight or one way ticket? Expert Rev Neurother 2008; 8: 1331-1337.
30. Del Sette M., Dinia L., Bonanzo L., et al. White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia 2008; 28: 376-382.
31. Bosca M., Tembl J., Bosca I., et al. Estudio de la relacion entre lesiones de sustancia blanca en la resonancia magnetica y foramen oval permeable en pacientes con migrana. Neurologia 2008; 23: 499-502.